CFTR and cystic fibrosis: Recently, we proposed a pharmacological approach based on the use of CFTR correctors, specifically developed for rescuing type II mutations of the Cystic Fibrosis Transmembrane Regulator (CFTR) (e.g., F508del-CFTR), causing cystic fibrosis [24].